​

Funding Round

Post-IPO Equity - Kymera Therapeutics

Post-IPO Equity - Kymera Therapeutics

Investment Firm

Overview

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Announced Date

Aug 19, 2022

Funding Type

Post Ipo Equity

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Biotechnology Value Fund

Biotechnology Value Fund

Biotechnology Value Fund is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

6

Investor Name
Participant InvestorBiotechnology Value Fund
Participant InvestorRedmile Group
Participant InvestorEcoR1 Capital
Participant InvestorAvoro Capital Advisors
Participant InvestorT. Rowe Price

Round Details and Background

Kymera Therapeutics raised $150000000 on 2022-08-19 in Post-IPO Equity

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 28, 2021
Post-IPO Equity - Kymera Therapeutics
-257.0M
Aug 19, 2022
Post-IPO Equity - Kymera Therapeutics
6-150.0M
Jan 05, 2024
Post-IPO Equity - Kymera Therapeutics
-275.0M
Oct 30, 2017
Series A - Kymera Therapeutics
3-30.0M

Recent Activity

There is no recent news or activity for this profile.